Trial Profile
A Phase I, Dose Escalation Study of BNC101 (Anti-LGR5 Humanized Monoclonal Antibody) in Patients With Metastatic Colorectal Cancer.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs BNC 101 (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Bionomics
- 23 Jul 2018 Status changed from active, no longer recruiting to discontinued.
- 21 Nov 2017 Planned primary completion date changed from 1 Apr 2019 to 1 Jan 2018.
- 21 Nov 2017 Status changed from recruiting to active, no longer recruiting.